GSK’s Gonorrhoea Drug Achieves Main Goal in Late-stage Trial
-
Medicines
GSK’s Gonorrhoea Drug Achieves Main Goal in Late-stage Trial
British pharmaceutical company GSK announced on Monday that its oral drug for treating gonorrhea, called gepotidacin, has met the primary…
Read More »
